The company has already been testing neural stem cells on human subjects in Switzerland. The recent approval will allow StemCells to conduct a trial in the U.S. and Canada aimed at showing how stem cells can improve or reverse effects of spinal cord paralysis.
Many scientists hope this approval will allow for more research gains to be made in the U.S. surrounding stem cells for regenerative medicine.
More Articles on Spine:
How Spine Surgeons Can Succeed With Consensus Building: Q&A With Dr. K. Daniel Riew
SpineCenterAtlanta Receives AAAASF Accreditation
Scoliosis Treatment: Do Race & Socioeconomic Status Make a Difference?
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
